Cargando…
Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung
There is increasing interest in the application of nanotechnology to solve the difficult problem of therapeutic administration of pharmaceuticals. Nanodiscs, composed of a stable discoidal lipid bilayer encircled by an amphipathic membrane scaffold protein that is an engineered variant of the human...
Autores principales: | Numata, Mari, Grinkova, Yelena V, Mitchell, James R, Chu, Hong Wei, Sligar, Stephen G, Voelker, Dennis R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663477/ https://www.ncbi.nlm.nih.gov/pubmed/23717040 http://dx.doi.org/10.2147/IJN.S39888 |
Ejemplares similares
-
Biotransformation of the Mycotoxin Enniatin B1 by CYP P450 3A4 and Potential for Drug-Drug Interactions
por: Ivanova, Lada, et al.
Publicado: (2019) -
Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4
por: Denisov, Ilia G., et al.
Publicado: (2022) -
Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids
por: Numata, Mari, et al.
Publicado: (2022) -
The continuing need for therapeutic agents for respiratory syncytial virus infection
por: Roberts, Norbert J
Publicado: (2023) -
Transmembrane Stem Factor Nanodiscs Enhanced Revascularization in a Hind Limb Ischemia Model in Diabetic, Hyperlipidemic Rabbits
por: Takematsu, Eri, et al.
Publicado: (2023)